ZA951588B - Antitussive composition - Google Patents

Antitussive composition

Info

Publication number
ZA951588B
ZA951588B ZA951588A ZA951588A ZA951588B ZA 951588 B ZA951588 B ZA 951588B ZA 951588 A ZA951588 A ZA 951588A ZA 951588 A ZA951588 A ZA 951588A ZA 951588 B ZA951588 B ZA 951588B
Authority
ZA
South Africa
Prior art keywords
pct
antitussive
sec
pharmaceutically acceptable
date
Prior art date
Application number
ZA951588A
Other languages
English (en)
Inventor
Depalmo Galli Angeli
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of ZA951588B publication Critical patent/ZA951588B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ZA951588A 1994-03-01 1995-02-24 Antitussive composition ZA951588B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940362A IT1274026B (it) 1994-03-01 1994-03-01 Composizione antitosse

Publications (1)

Publication Number Publication Date
ZA951588B true ZA951588B (en) 1995-12-08

Family

ID=11368015

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951588A ZA951588B (en) 1994-03-01 1995-02-24 Antitussive composition

Country Status (27)

Country Link
US (1) US5932589A (de)
EP (1) EP0748222B1 (de)
JP (1) JP3348858B2 (de)
KR (1) KR970701047A (de)
CN (1) CN1088358C (de)
AT (1) ATE195074T1 (de)
AU (1) AU681257B2 (de)
BR (1) BR9506956A (de)
CA (1) CA2184594C (de)
CZ (1) CZ284798B6 (de)
DE (1) DE69518229T2 (de)
DK (1) DK0748222T3 (de)
ES (1) ES2149969T3 (de)
FI (1) FI963394A7 (de)
GR (1) GR3034665T3 (de)
HU (1) HUT75937A (de)
IT (1) IT1274026B (de)
NO (1) NO309965B1 (de)
NZ (1) NZ281230A (de)
PL (1) PL178608B1 (de)
PT (1) PT748222E (de)
RO (1) RO117147B1 (de)
RU (1) RU2143901C1 (de)
SK (1) SK282567B6 (de)
UA (1) UA37278C2 (de)
WO (1) WO1995023602A1 (de)
ZA (1) ZA951588B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124282A (en) * 1997-05-22 2000-09-26 Sellers; Edward M. Drug formulations
DK1685839T3 (da) * 1997-12-22 2013-06-24 Euro Celtique Sa Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
EP1181010A4 (de) * 1999-04-06 2003-03-26 Wrigley W M Jun Co Pharmazeutische kaugummiformulierungen
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
ES2343641T3 (es) * 2005-01-14 2010-08-05 Camurus Ab Formulaciones bioadhesivas topicas.
CN101219140B (zh) * 2007-12-24 2011-06-01 重庆市莱美药物技术有限公司 盐酸苄达明可溶片及其制备方法
MX2012000498A (es) 2009-07-08 2012-04-30 Acraf Uso de bencidamina en el tratamiento de enfermedades dependientes de p40.
WO2014159340A1 (en) * 2013-03-13 2014-10-02 Tris Pharma, Inc. Benzonatate modified release solid tablets and capsules
WO2016128991A1 (en) * 2015-02-09 2016-08-18 Cellix Bio Private Limited Compositions and methods for the treatment of mucositis
WO2018191477A1 (en) * 2017-04-14 2018-10-18 Kempharm, Inc. Dextrorphan prodrugs and processes for making and using them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (de) * 1963-08-09
FI931934L (fi) * 1990-10-31 1993-05-31 Procter & Gamble Dextrometorfaninnehaollande hostmedicinkompositioner
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions

Also Published As

Publication number Publication date
DE69518229D1 (de) 2000-09-07
AU681257B2 (en) 1997-08-21
NO963634L (no) 1996-08-30
HU9602390D0 (en) 1996-10-28
DE69518229T2 (de) 2001-03-08
EP0748222B1 (de) 2000-08-02
NZ281230A (en) 1998-04-27
NO963634D0 (no) 1996-08-30
ITMI940362A1 (it) 1995-09-01
CN1143909A (zh) 1997-02-26
MX9603747A (es) 1997-12-31
RU2143901C1 (ru) 2000-01-10
SK282567B6 (sk) 2002-10-08
JP3348858B2 (ja) 2002-11-20
CA2184594A1 (en) 1995-09-08
CA2184594C (en) 2002-09-17
UA37278C2 (uk) 2001-05-15
PT748222E (pt) 2001-01-31
RO117147B1 (ro) 2001-11-30
GR3034665T3 (en) 2001-01-31
WO1995023602A1 (en) 1995-09-08
CZ284798B6 (cs) 1999-03-17
SK108596A3 (en) 1997-04-09
US5932589A (en) 1999-08-03
PL178608B1 (pl) 2000-05-31
ES2149969T3 (es) 2000-11-16
KR970701047A (ko) 1997-03-17
FI963394A0 (fi) 1996-08-30
CN1088358C (zh) 2002-07-31
IT1274026B (it) 1997-07-14
BR9506956A (pt) 1997-09-16
ITMI940362A0 (it) 1994-03-01
HUT75937A (en) 1997-05-28
EP0748222A1 (de) 1996-12-18
FI963394L (fi) 1996-08-30
PL316079A1 (en) 1996-12-23
JPH09509670A (ja) 1997-09-30
ATE195074T1 (de) 2000-08-15
FI963394A7 (fi) 1996-08-30
DK0748222T3 (da) 2000-12-18
CZ253296A3 (en) 1997-01-15
NO309965B1 (no) 2001-04-30
AU1811695A (en) 1995-09-18

Similar Documents

Publication Publication Date Title
AU1947895A (en) Sublingual or buccal pharmaceutical composition
EG22373A (en) New pharmaceutical formulation
PL327923A1 (en) Novel combination of active ingredients containing clopidogrel and antithrombotic drug
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
CA2279497A1 (en) The use of levobupivacaine in facial surgery
GR3034665T3 (en) Antitussive composition containing an antitussive and benzydamine
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
CA2313618A1 (en) Transmucosal formulations of levosimendan
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
CA2077693A1 (en) Use of ketorolac for treatment of periodontal disease
AU6519596A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
WO2002051404A8 (fr) Compositions orales
AU7436098A (en) Use of mizolastine for preparing a medicine for treating inflammation
HK1002658A1 (en) Imidazopyridine-azolidinones, their preparation and pharmaceutical use